thiazoles has been researched along with desferrithiocin in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (18.92) | 18.7374 |
1990's | 15 (40.54) | 18.2507 |
2000's | 9 (24.32) | 29.6817 |
2010's | 6 (16.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, E; Jacobs, A; Peter, H; Wong, A | 1 |
Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, D | 1 |
Cook, EP; Fragonas, JC; Hunt, NH | 1 |
Bergeron, RJ; Dionis, JB; Egli-Karmakka, M; Frei, J; Huxley-Tencer, A; Peter, HH; Wiegand, J | 1 |
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J | 1 |
Bierer, BE; Nathan, DG | 1 |
Wolfe, LC | 1 |
Chaudhri, G; Clark, IA | 1 |
Finger, J; Hegsted, M; Nathan, DG; Nicolosi, RJ; Peter, H; Renaud, MM; Wolfe, LC | 1 |
Baquet, A; Crichton, RR; Florence, A; Jin, Y; Schneider, YJ | 1 |
Cochrane, CG; Hyslop, PA; Jackson, JH; Sauerheber, R; Schraufstatter, IU; Vosbeck, K; Weitzman, SA | 1 |
Hiller, W; Maichle, C; Schechinger, T; Strähle, J; Weser, U | 1 |
Beaudoin, RL; Gentilini, M; Guillouzo, A; Landau, I; Langlois, P; Mazier, D; Mellouk, S; Miltgen, F; Stahel, E | 1 |
Crichton, RR; Longueville, A | 1 |
Bergeron, RJ; Wiegand, J; Wollenweber, M | 1 |
Algee, SE; Bergeron, RJ; Liu, CZ; McManis, JS; Wiegand, J; Xia, MX | 1 |
DeSousa, M; Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, WD | 1 |
Bergeron, RJ; Creary, EA; Daniels, RD; King, W; Luchetta, G; Moerker, T; Peter, HH; Streiff, RR; Wiegand, J | 1 |
Algee, SE; Bergeron, RJ; McManis, JS; Ratliff-Thompson, K; Wiegand, J; Wollenweber, M | 1 |
Crichton, RR; Dexter, DT; Florence, A; Jenner, P; Ward, RJ | 1 |
Bergeron, RJ; Brittenham, GM; Bussenius, J; McManis, JS; Wiegand, J | 1 |
Bergeron, RJ; Weimar, WR; Wiegand, J | 1 |
Baker, E; Chua, AC; Kicic, A | 1 |
Bergeron, RJ; Huang, G; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J | 1 |
Bergeron, RJ; Huang, G; McManis, JS; Weimar, WR; Wiegand, J | 1 |
Bergeron, RJ; Nguyen, JN; Sninsky, CA; Weimar, WR; Wiegand, J | 1 |
Acklin, P; Alberti, D; Buehlmayer, P; Hauffe, S; Lattmann, R; Nick, H; Schupp, J | 1 |
Bergeron, J; Bergeron, RJ; Brittenham, GM; Eiler-McManis, E; McManis, JS; Park, JH; Weimar, WR; Wiegand, J | 1 |
Hider, RC; Zhou, T | 1 |
Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J | 2 |
Bergeron, RJ; Singh, S; Wiegand, J | 1 |
Abboud, KA; Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J | 1 |
Bergeron, RJ; Bharti, N; McManis, JS; Wiegand, J | 2 |
Aydinok, Y; Berk, G; Cohen, AR; Giardina, PJ; Jeglinski, BI; Kuo, KH; Kwiatkowski, JL; Neufeld, EJ; Pietropaolo, K; Saliba, AN; Taher, AT; Viprakasit, V | 1 |
Dev, A; Jayaprakash, V; Shyam, M; Sinha, BN | 1 |
4 review(s) available for thiazoles and desferrithiocin
Article | Year |
---|---|
Structure-activity relationships among desazadesferrithiocin analogues.
Topics: Animals; Dihydropyridines; Drug Design; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Siderophores; Structure-Activity Relationship; Thiazoles | 2002 |
Development of tridentate iron chelators: from desferrithiocin to ICL670.
Topics: Animals; Benzoates; Callithrix; Chemical Phenomena; Chemistry, Physical; Deferasirox; Dihydropyridines; Dogs; Humans; Iron; Iron Chelating Agents; Rats; Thiazoles; Triazoles | 2003 |
Desferrithiocin: a search for clinically effective iron chelators.
Topics: Animals; Chemistry, Pharmaceutical; Dihydropyridines; Drug Design; Electron Transport; Ferritins; Homeostasis; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Oxidation-Reduction; Primates; Rats; Rats, Sprague-Dawley; Siderophores; Structure-Activity Relationship; Thiazoles; Transferrin | 2014 |
Scaffold Based Search on the Desferithiocin Archetype.
Topics: Benzene Derivatives; Dihydropyridines; Humans; Iron Chelating Agents; Iron Overload; Pyridines; Structure-Activity Relationship; Thiazoles | 2019 |
1 trial(s) available for thiazoles and desferrithiocin
Article | Year |
---|---|
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Cyclohexanones; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Kidney Diseases; Middle Aged; Siderophores; Thiazoles; Young Adult | 2017 |
32 other study(ies) available for thiazoles and desferrithiocin
Article | Year |
---|---|
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain | 1992 |
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
Topics: Animals; Cytokines; Dihydropyridines; Graft Survival; Heart Transplantation; Iron Chelating Agents; Lymphocyte Activation; Macrophage Activation; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Receptors, Interleukin-2; T-Lymphocytes; Thiazoles; Transplantation, Homologous | 1992 |
Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes.
Topics: Animals; B-Lymphocytes; Deferoxamine; Dihydropyridines; DNA; Ferricyanides; Humans; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxygen; T-Lymphocytes; Thiazoles | 1991 |
Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.
Topics: Administration, Oral; Animals; Bile; Chemical Phenomena; Chemistry; Dihydropyridines; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazoles | 1991 |
A comparative evaluation of iron clearance models.
Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles | 1990 |
The effect of desferrithiocin, an oral iron chelator, on T-cell function.
Topics: Antigens, Surface; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Cytotoxicity, Immunologic; Deferoxamine; Dihydropyridines; Humans; Interleukin-2; Iron; Iron Chelating Agents; Killer Cells, Natural; Lymphocyte Activation; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thiazoles | 1990 |
Desferrithiocin.
Topics: Animals; Dihydropyridines; Iron Chelating Agents; Thiazoles | 1990 |
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.
Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Deferoxamine; Dihydropyridines; Free Radicals; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred CBA; Oxygen; Peritoneal Cavity; Thiazoles; Tumor Necrosis Factor-alpha | 1989 |
A non-human primate model for the study of oral iron chelators.
Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Dihydropyridines; Disease Models, Animal; Injections, Intramuscular; Iron; Iron Chelating Agents; Thiazoles | 1989 |
Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization.
Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Iron; Liver; Male; Rats; Rats, Inbred Strains; Thiazoles; Tritium | 1989 |
Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke.
Topics: Asbestos; Bacteriophages; Benzoates; Benzoic Acid; Catalase; Dihydropyridines; Dimethyl Sulfoxide; DNA; Drug Synergism; Electron Spin Resonance Spectroscopy; Hydroxides; Hydroxyl Radical; Mannitol; Nucleic Acid Conformation; Phenanthrolines; Smoking; Superoxide Dismutase; Thiazoles | 1987 |
A five-coordinate copper complex with superoxide dismutase mimetic activity from Streptomyces antibioticus.
Topics: Circular Dichroism; Copper; Dihydropyridines; Electron Spin Resonance Spectroscopy; Iron Chelating Agents; Models, Molecular; Spectrophotometry; Streptomyces; Streptomyces antibioticus; Superoxide Dismutase; Thermodynamics; Thiazoles; X-Ray Diffraction | 1988 |
Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Humans; Iron Chelating Agents; Liver; Malaria; Microscopy, Electron; Plasmodium falciparum; Plasmodium yoelii; Rats; Thiazoles | 1988 |
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles | 1986 |
An investigation of desferrithiocin metabolism.
Topics: Animals; Chromatography, High Pressure Liquid; Cysteine; Dihydropyridines; Female; Hydrolysis; Iron; Kinetics; Male; Mice; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles | 1994 |
The desferrithiocin pharmacophore.
Topics: Animals; Dihydropyridines; Drug Design; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1994 |
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
Topics: Animals; Cell Movement; Dihydropyridines; Graft Survival; Heart Transplantation; Iron; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Siderophores; T-Lymphocyte Subsets; Thiazoles; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 1993 |
A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
Topics: Animals; Cebus; Deferoxamine; Dihydropyridines; Feces; Gastrointestinal Diseases; Iron; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles | 1993 |
Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators.
Topics: Animals; Cebus; Dihydropyridines; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Thiazoles | 1996 |
Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
Topics: Administration, Oral; Animals; Corpus Striatum; Dihydropyridines; Dopamine; Ferrous Compounds; In Vitro Techniques; Iron; Iron Chelating Agents; Iron Overload; Male; Metallocenes; Rats; Rats, Wistar; Serotonin; Thiazoles | 1999 |
Evaluation of the desferrithiocin pharmacophore as a vector for hydroxamates.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Drug Evaluation, Preclinical; Hydroxamic Acids; Injections, Subcutaneous; Iron Chelating Agents; Iron Overload; Ligands; Male; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles | 1999 |
Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Humans; Iron Chelating Agents; Serum Albumin; Thiazoles | 1999 |
Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Fibroblasts; Hepatocytes; Humans; Iron; Iron Chelating Agents; Male; Mice; Rats; Rats, Wistar; Thiazoles; Tumor Cells, Cultured | 2002 |
Desferrithiocin analogue based hexacoordinate iron(III) chelators.
Topics: Animals; Ascorbic Acid; Bile; Cebus; Dihydropyridines; Feces; Free Radical Scavengers; Iron; Iron Chelating Agents; Ligands; Oxidation-Reduction; Resorcinols; Structure-Activity Relationship; Thiazoles | 2003 |
Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.
Topics: Acetic Acid; Animals; Colitis; Dihydropyridines; Disease Models, Animal; Drug Interactions; Intestinal Mucosa; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Thiazoles | 2003 |
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.
Topics: Animals; Antioxidants; Ascorbic Acid; Catechols; Cebus; Dihydropyridines; Free Radical Scavengers; Humans; In Vitro Techniques; Iron; Iron Chelating Agents; Liver; Male; Myocardium; Oxidation-Reduction; Pancreas; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Tissue Distribution | 2005 |
The design of orally active iron chelators.
Topics: Administration, Oral; Benzoates; Clinical Trials as Topic; Deferasirox; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Humans; Iron; Iron Chelating Agents; Ligands; Models, Molecular; Molecular Structure; Oxidation-Reduction; Pyridones; Thiazoles; Triazoles | 2005 |
Desferrithiocin analogues and nephrotoxicity.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Ligands; Lipids; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Water | 2008 |
Desferrithiocin analogue uranium decorporation agents.
Topics: Animals; Bile Ducts; Chelating Agents; Dihydropyridines; Dose-Response Relationship, Drug; Femur; Kidney; Ligands; Liver; Lung; Pentetic Acid; Rats; Spleen; Thiazoles; Uranium | 2009 |
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.
Topics: Animals; Bile Ducts; Cebus; Chemical Phenomena; Crystallography, X-Ray; Dihydropyridines; Drug Design; Ether; Ethers; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Octanols; Rats; Thiazoles; Water | 2010 |
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity.
Topics: Animals; Cebus; Cell Adhesion Molecules; Dihydropyridines; Feces; Iron; Iron Chelating Agents; Kidney; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Thiazoles | 2011 |
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
Topics: Administration, Oral; Animals; Cebus; Coordination Complexes; Dihydropyridines; Ethers; Ferric Compounds; Hydroxylation; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2012 |